Table 1

Baseline characteristics of the study sample, stratified according to use of home oxygen therapy

CharacteristicsBefore matching (N=36 761)After matching (1:1; N=2478)
Yes, n (%)No, n (%)p ValueYes, n (%)No, n (%)p Value
1330(3.6)35 431(96.4)1239(50.0)1239(50.0)
Age (years), mean (SD)67.1(9.6)63.8(12.0)<0.000167.4(9.7)68.0(9.9)0.14
Sex
 Male964(4.7)19 353(95.3)<0.0001884(49.2)912(50.8)0.21
 Female367(2.2)16 078(97.8) 355(52.0)327(48.0) 
Health insurance type
 National health insurance1279(3.8)32 645(96.2)<0.00011188(50.5)1163(49.5)0.02
 Medical aid51(1.8)2786(98.2) 51(40.2)76(59.8) 
Charlson Comorbidity Index*
 0692(6.5)9983(93.5)<0.0001628(48.4)670(51.6)0.13
 162(5.7)1021(94.3) 57(47.1)64(52.9) 
 ≥2576(2.3)24 427(97.7) 554(52.3)505(47.7) 
ICU use
 Yes11(6.9)148(93.1)<0.00019(39.1)12(60.9)0.30
 No1319(3.6)35 283(96.4) 1230(50.1)1225(49.9) 
Number of hospital admissions
 01147(3.5)31 923(96.5)<0.00011067(51.5)1004(48.5)0.002
 1127(4.9)2486(95.1) 119(40.6)174(59.4) 
 ≥256(5.2)1022(94.8) 53(46.5)61(53.5) 
Respiratory impairment rating
 Grade 1 (predicted FEV1 ≤25% or PaO2 ≤55 mm Hg)163(43.2)214(56.8)<0.000191(43.1)120(56.9)0.001
 Grade 2 (predicted FEV1 ≤30% or PaO2 ≤60 mm Hg)121(35.6)219(64.4) 102(55.7)81(44.3) 
 Grade 3 (predicted FEV1 ≤40% or PaO2 ≤65 mm Hg)110(26.6)304(73.4) 110(61.1)70(38.9) 
 No grade936(2.6)34 694(97.4) 936(49.2)968(50.8) 
  • *Calculated comorbidity component; subtracted age scores.

  • ICU, intensive care unit.